Insider · CIK 0001656633

CRYSTAL ROGER

Reports to the SEC for 2 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001656633

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-11	DFTXDefinium Therapeutics, Inc.A Award	Director	AAward	+4,666 sh	—	—	24,289
2026-06-11	DFTXDefinium Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+19.2K sh	—	—	19,188
2025-06-12	DFTXDefinium Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+75.2K sh	—	—	75,187
2024-06-10	DFTXDefinium Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16.5K sh	—	—	16,506
2023-06-21	DFTXDefinium Therapeutics, Inc.A Award	Director	AAward	+13.7K sh	—	—	19,623
2023-06-21	DFTXDefinium Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+19.2K sh	—	—	27,267
2023-03-02	OPIANT PHARMACEUTICALS, INC.Stock Option (right to buy)D Disposition to Issuer	Director, Chief Executive Officer, 10% Owner	DDisposition to Issuer	−31.3K sh	—	—	0
2023-03-02	OPIANT PHARMACEUTICALS, INC.D Disposition to Issuer	Director, Chief Executive Officer, 10% Owner	DDisposition to Issuer	−37.4K sh	$20.00	−$749K	37,901
2023-03-02	OPIANT PHARMACEUTICALS, INC.D Disposition to Issuer	Director, Chief Executive Officer, 10% Owner	DDisposition to Issuer	−37.9K sh	$20.00	−$758K	0
2023-03-02	OPIANT PHARMACEUTICALS, INC.D Disposition to Issuer	Director, Chief Executive Officer, 10% Owner	DDisposition to Issuer	−5,100 sh	$20.00	−$102K	0
2023-03-02	OPIANT PHARMACEUTICALS, INC.A Award	Director, Chief Executive Officer, 10% Owner	AAward	+6,667 sh	—	—	6,667
2023-03-02	OPIANT PHARMACEUTICALS, INC.D Disposition to Issuer	Director, Chief Executive Officer, 10% Owner	DDisposition to Issuer	−6,667 sh	$20.00	−$133K	0
2023-03-02	OPIANT PHARMACEUTICALS, INC.OptionD Disposition to Issuer	Director, Chief Executive Officer, 10% Owner	DDisposition to Issuer	−25K sh	—	—	0
2023-03-02	OPIANT PHARMACEUTICALS, INC.OptionD Disposition to Issuer	Director, Chief Executive Officer, 10% Owner	DDisposition to Issuer	−150K sh	—	—	0
2023-03-02	OPIANT PHARMACEUTICALS, INC.OptionD Disposition to Issuer	Director, Chief Executive Officer, 10% Owner	DDisposition to Issuer	−375K sh	—	—	0
2023-03-02	OPIANT PHARMACEUTICALS, INC.OptionD Disposition to Issuer	Director, Chief Executive Officer, 10% Owner	DDisposition to Issuer	−25K sh	—	—	0
2023-03-02	OPIANT PHARMACEUTICALS, INC.Stock Option (right to buy)D Disposition to Issuer	Director, Chief Executive Officer, 10% Owner	DDisposition to Issuer	−13.2K sh	—	—	0
2023-03-02	OPIANT PHARMACEUTICALS, INC.Common StockD Disposition to Issuer	Director, Chief Executive Officer, 10% Owner	DDisposition to Issuer	−27.3K sh	—	—	0
2023-01-27	OPIANT PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer, 10% Owner	SSale	−1,358 sh	$20.26	−$27.5K	75,339
2023-01-09	OPIANT PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer, 10% Owner	SSale	−1,183 sh	$20.20	−$23.9K	76,697
2023-01-05	OPIANT PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer, 10% Owner	SSale	−5,029 sh	$20.20	−$102K	77,880
2022-08-11	DFTXDefinium Therapeutics, Inc. · Director's Deferred Share UnitsA Award	Director	AAward	+504K sh	—	—	503,773
2022-08-11	DFTXDefinium Therapeutics, Inc.A Award	Director	AAward	+89.3K sh	—	—	89,286
2022-08-11	DFTXDefinium Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+121K sh	—	—	120,968
2022-07-14	OPIANT PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer, 10% Owner	SSale	−2,246 sh	$11.11	−$25K	82,909
2022-06-27	OPIANT PHARMACEUTICALS, INC.A Award	Director, Chief Executive Officer, 10% Owner	AAward	+6,667 sh	—	—	85,155
2022-01-27	OPIANT PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer, 10% Owner	SSale	−1,995 sh	$26.15	−$52.2K	78,488
2022-01-10	OPIANT PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer, 10% Owner	SSale	−1,058 sh	$30.49	−$32.3K	80,483
2022-01-04	OPIANT PHARMACEUTICALS, INC.A Award	Director, Chief Executive Officer, 10% Owner	AAward	+40K sh	—	—	81,541
2021-09-16	OPIANT PHARMACEUTICALS, INC.P Purchase	Director, Chief Executive Officer, 10% Owner	PPurchase	+100 sh	$23.44	+$2,344	5,100
2021-01-26	OPIANT PHARMACEUTICALS, INC.A Award	Director, Chief Executive Officer, 10% Owner	AAward	+3,766 sh	—	—	25,891
2021-01-26	OPIANT PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Director, Chief Executive Officer, 10% Owner	AAward	+31.3K sh	—	—	31,250
2021-01-26	OPIANT PHARMACEUTICALS, INC.A Award	Director, Chief Executive Officer, 10% Owner	AAward	+15.7K sh	—	—	41,541
2020-01-07	OPIANT PHARMACEUTICALS, INC.A Award	Director, Chief Executive Officer, 10% Owner	AAward	+13.7K sh	—	—	22,125
2020-01-07	OPIANT PHARMACEUTICALS, INC.Common StockA Award	Director, Chief Executive Officer, 10% Owner	AAward	+27.3K sh	—	—	27,250
2019-04-08	OPIANT PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer, 10% Owner	SSale	−12.8K sh	$12.10	−$155K	8,475
2019-04-05	OPIANT PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer, 10% Owner	SSale	−16K sh	$11.98	−$192K	21,247
2019-04-05	OPIANT PHARMACEUTICALS, INC.M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	+21.5K sh	$7.25	+$156K	37,248
2019-04-05	OPIANT PHARMACEUTICALS, INC.OptionM Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	−21.5K sh	$7.25	−$156K	375,000
2019-04-04	OPIANT PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer, 10% Owner	SSale	−16.8K sh	$11.93	−$201K	15,776
2019-04-04	OPIANT PHARMACEUTICALS, INC.M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	+22.6K sh	$7.25	+$164K	32,612
2019-04-04	OPIANT PHARMACEUTICALS, INC.OptionM Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	−22.6K sh	$7.25	−$164K	396,472
2019-04-03	OPIANT PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer, 10% Owner	SSale	−3,791 sh	$12.24	−$46.4K	10,055
2019-04-03	OPIANT PHARMACEUTICALS, INC.M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	+5,149 sh	$7.25	+$37.3K	14,446
2019-04-03	OPIANT PHARMACEUTICALS, INC.OptionM Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	−5,149 sh	$7.25	−$37.3K	419,029
2019-04-02	OPIANT PHARMACEUTICALS, INC.OptionM Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	−822 sh	$7.25	−$5,959.5	424,178
2019-04-02	OPIANT PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer, 10% Owner	SSale	−600 sh	$12.48	−$7,488	13,846
2019-04-02	OPIANT PHARMACEUTICALS, INC.M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	+822 sh	$7.25	+$5,959.5	9,297
2019-01-15	OPIANT PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Director, Chief Executive Officer, 10% Owner	AAward	+13.2K sh	—	—	13,200
2019-01-08	OPIANT PHARMACEUTICALS, INC.S Sale	Director, Chief Executive Officer, 10% Owner	SSale	−11.4K sh	$13.27	−$151K	8,475

Recent filings

Accepted (ET)
Jun 154
CRYSTAL ROGER0001193125-26-271164
SEC(opens sec.gov)
Jun 164
CRYSTAL ROGER0000950170-25-086764
SEC(opens sec.gov)
Jun 124
CRYSTAL ROGER0000950170-24-072454
SEC(opens sec.gov)
Jun 234
CRYSTAL ROGER0000899243-23-016423
SEC(opens sec.gov)
Mar 34
CRYSTAL ROGER0001385508-23-000069
SEC(opens sec.gov)
Jan 314
CRYSTAL ROGER0001385508-23-000034
SEC(opens sec.gov)
Jan 94
CRYSTAL ROGER0001385508-23-000018
SEC(opens sec.gov)

Companies

Address

C/O DEFINIUM THERAPEUTICS, INC. ONE WORLD TRADE CENTER, SUITE 8500

NEW YORK, NY, 10007